A Phase I Study with Sodium Trans-[Tetrachlorobis (1h-Indazole)Ruthenate(III)]/Indazolhydrochloride (Ffc14a) in Patients with Solid Tumors

L39

  • Scheulen, M. E.

  • Innere Klinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, Essen, Germany

Onkologie 26(4):p 395-396, August 2003.
Copyright © 2003 S. Karger AG, Basel